BUDAPEST, Dec 27 (Reuters) - Hungary's pharma company
Richter GDRB.BU expects extra profit taxes payable by the
company for the year 2022 to be approximately 28 billion forints
($74.44 million), the company said in a statement on Tuesday.
Hungary's government announced late on Friday that a
windfall tax imposed on drug producers based on net revenues
generated in 2022 and 2023 will increase progressively, and will
be 8% on net revenues exceeding 150 billion forints ($398
million).
($1 = 376.1500 forints)
(Reporting by Anita Komuves)
((KOMUVES.Anita@thomsonreuters.com;))